Tipifarnib

tipifarnib · Kura Oncology, Inc.

Drug timelines are a Plus or Pro feature.

58 regulatory and trial events tracked for Tipifarnib, covering 2009-08-14 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma [Phase 2]